Dr. Kerr maintains an active clinical practice in rheumatology, including providing consultative services for other sub-specialists at the Medical Center. Since the mid-1980s, Dr. Kerr initiated and has expanded rheumatology clinics at North General Hospital, bringing expertise in rheumatology to an area in East Harlem where none previously existed. Her research has included studies of tumor necrosis factor inhibition for the treatment of severe psoriatic arthritis. She has a particular interest in geriatric rheumatology and runs a rheumatology clinic within the Coffey Geriatric Practice. In addition, she developed the Annenberg Connective tissue Disease clinic, run with our fellows, which is a significant component of of the rotation for this speciality for residents and medical students. The complexity and challenging nature of inner city connective tissue disease, have led to this clinic becoming a referral resource for clinical trials and observational studies.
Dr. Kerr is no longer accepting new patients.
Language
English
Position
PROFESSOR | Medicine, Rheumatology, PROFESSOR | Geriatrics and Palliative Medicine
Hospital Affiliations
Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
The Mount Sinai Hospital
Mount Sinai West
About Me
Dr. Kerr maintains an active clinical practice in rheumatology, including providing consultative services for other sub-specialists at the Medical Center. Since the mid-1980s, Dr. Kerr initiated and has expanded rheumatology clinics at North General Hospital, bringing expertise in rheumatology to an area in East Harlem where none previously existed. Her research has included studies of tumor necrosis factor inhibition for the treatment of severe psoriatic arthritis. She has a particular interest in geriatric rheumatology and runs a rheumatology clinic within the Coffey Geriatric Practice. In addition, she developed the Annenberg Connective tissue Disease clinic, run with our fellows, which is a significant component of of the rotation for this speciality for residents and medical students. The complexity and challenging nature of inner city connective tissue disease, have led to this clinic becoming a referral resource for clinical trials and observational studies.
Dr. Kerr is no longer accepting new patients.
Language
English
Position
PROFESSOR | Medicine, Rheumatology, PROFESSOR | Geriatrics and Palliative Medicine
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
Department of Medicine-Rheumatology17 East 102nd Street, 2nd Floor, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
CIGNA Healthcare
Centivo
Cigna - Medicare
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - HealthPlus Medicaid
Empire Blue Cross Blue Shield - Medicare
Fidelis Health Care
HealthFirst Medicaid
HealthFirst Medicare
Horizon NJ
Hotel Trades
Humana Medicare
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Metroplus
Multiplan PHCS
NJ Medicaid
NY Medicaid
Oscar
Oxford - Freedom and Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VNSNY Select Health Medicaid
VillageCareMax
WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Kerr has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Kerr has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai DoctorsTreats Adults